title: Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.
authors.affiliation: Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Italy sluminari@unimore.it.
authors.forename: Stefano
authors.initials: S
authors.lastname: Luminari
authors.affiliation: Department of Internal and Experimental Medicine, University of Pisa, UO Hematology, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Galimberti
authors.affiliation: Department of Nuclear Medicine, Arcispedale S. Maria Nuova - IRCCS of Reggio Emilia, Italy.
authors.forename: Annibale
authors.initials: A
authors.lastname: Versari
authors.affiliation: Department of Medicine, University Hospital and School of Medicine, Universidade Federal do Rio de Janeiro, Brazil.
authors.forename: Irene
authors.initials: I
authors.lastname: Biasoli
authors.affiliation: Hematology Unit, Spedali Civili di Brescia, Italy.
authors.forename: Antonella
authors.initials: A
authors.lastname: Anastasia
authors.affiliation: Division of Hematology, Department of Hematology and Oncology, Niguarda Hospital, Milan, Italy.
authors.forename: Chiara
authors.initials: C
authors.lastname: Rusconi
authors.affiliation: Hematology Unit, Arcispedale Santa Maria Nuova, IRCCS of Reggio Emilia, Italy.
authors.forename: Angela
authors.initials: A
authors.lastname: Ferrari
authors.affiliation: Department of Internal and Experimental Medicine, University of Pisa, UO Hematology, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
authors.affiliation: Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Italy.
authors.forename: Martina
authors.initials: M
authors.lastname: Manni
authors.affiliation: Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Federico
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000235:genetics*; D018572:Disease-Free Survival; D005260:Female; D019788:Fluorodeoxyglucose F18 / Q000032:analysis*; D015870:Gene Expression; D006801:Humans; D008224:Lymphoma, Follicular / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality / Q000473:pathology; D008297:Male; D008875:Middle Aged; D018365:Neoplasm, Residual; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals / Q000032:analysis*; D060888:Real-Time Polymerase Chain Reaction; D012008:Recurrence
chemical_list: C582872:BCL2-IgH fusion protein, human; D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18
keywords: FDG-PET; follicular lymphoma; minimal residual disease; nuclear medicine; progression-free survival